Financial Performance - For the fiscal year ended September 30, 2023, the company reported revenues of RMB 93,307,000, which is expected to increase to RMB 113,381,000 in 2024, but projected to decline to RMB 91,290,000 in 2025, indicating a fluctuation in revenue trends [64]. - The gross profit for 2023 was RMB 17,247,000, which decreased to RMB 16,067,000 in 2024 and is projected to further decline to RMB 6,393,000 in 2025, reflecting challenges in maintaining profitability [64]. - The company incurred a net loss of RMB 57,964,000 in 2025, following a net income of RMB 62,669,000 in 2023 and RMB 18,678,000 in 2024, highlighting a significant downturn in financial performance [64]. - Total assets decreased from RMB 131,562,000 in 2024 to RMB 100,647,000 in 2025, while total liabilities also reduced from RMB 190,161,000 to RMB 162,163,000 during the same period [65]. - The company reported a current working capital deficit of RMB 84,535,000 in 2024, slightly improving to RMB 83,256,000 in 2025, indicating ongoing liquidity challenges [66]. Capital and Investment - The company has raised approximately $5.36 million (RMB 38.26 million) through the sale of shares under an "at the market" arrangement, but still requires additional capital to sustain operations [75]. - The company entered into a Cooperation Framework Agreement with BC-TID, resulting in an investment of RMB 137.7 million (US$20.2 million) for a new entity, with BC-TID owning 51% and the company owning 49% [186]. - The company has established three new seed distribution joint ventures in Xuzhou, Anhui, and Hubei, each held at 65% [189]. Market and Competition - The company faces competition from traditional seed products and international players in the GM seed market, necessitating a focus on innovation and market adaptation [72]. - The company is a leader in corn seed biotechnology in China, but faces competition from multinational corporations with greater resources and advanced technologies, which could affect product acceptance [86]. - The GM seed market outside China is dominated by major companies like Monsanto and Corteva Agriscience, which hold approximately 70% of the U.S. market, posing a threat to the company's sales and licensing opportunities [87]. - The seed business is highly competitive, with both domestic and international players, and pricing pressures from traditional seed producers may negatively impact financial results [85]. - The company faces significant challenges in obtaining necessary approvals for genetically modified (GM) corn products, which could adversely impact future development and recovery of R&D costs [78]. Regulatory Environment - Regulatory uncertainties regarding genetically modified organisms (GMOs) in China could adversely affect the company's ability to commercialize its biotech products, impacting overall business strategy [77]. - Compliance with foreign regulatory requirements is costly and may hinder the company's ability to distribute products outside China, where rigorous testing and pre-approval are mandatory [79]. - Compliance with evolving PRC regulations is critical; failure to adhere could result in fines or operational restrictions, adversely affecting revenues [101]. - The PRC government may impose penalties or require restructuring of operations if the VIE agreements are found non-compliant with regulations [145]. - The Foreign Investment Law, effective January 1, 2020, introduces uncertainties regarding the classification of VIEs and their compliance with market access requirements for foreign investment [160]. Research and Development - The company plans to continue developing new seed traits to maintain its biotech pipeline, which is crucial for future growth and competitiveness in the market [72]. - The company has developed transgenic corn seed products, including first-generation biotech products and stacked traits of Bt and glyphosate tolerance genes [182]. - The company has established several plant genetic engineering technology platforms focusing on traits such as herbicide tolerance, insect resistance, and drought stress tolerance in corn [200]. - The company has created a corn gene editing experimental platform since 2017, developing traits like high lutein and high lysine, currently under verification [209]. - The company is in the process of applying for GMO Biosafety certificates and is actively discussing requirements with relevant authorities [234]. Intellectual Property - Intellectual property rights are crucial for the company, and potential infringement claims could lead to substantial legal expenses and disrupt business operations [94]. - Intellectual property protection in China remains underdeveloped, increasing risks for the company in safeguarding its innovations [97]. - The company holds four Chinese patents and 27 trademarks related to its seed products, with additional patents pending [203]. - Hainan Aoyu and Origin Agriculture hold all intellectual property rights, managed through Exclusive Master Service Agreements and Business Cooperation Agreements [257]. Operational Risks - The company utilizes joint ventures in China for its seed business, which presents financial, managerial, and operational risks that could adversely affect revenues and cash flows [81]. - The company operates through variable interest entities (VIEs) in China, facing regulatory uncertainties that could adversely affect financial performance and enforceability of agreements [139]. - The legality and enforceability of the VIE arrangements have not been tested in court, posing risks to the company's reported ownership and financial statements [142]. - Any failure by the VIE or its shareholders to perform obligations could materially affect the company's business and financial condition [151]. - Shareholders of the VIE may have conflicts of interest that could adversely affect the company's control and economic benefits from the VIE [154]. Taxation and Financial Compliance - The applicable enterprise income tax rate for the company and its operating entities is 25% under the new EIT law [241]. - The company is subject to a 10% withholding tax on dividends payable to foreign investors from PRC sources, with no tax treaty currently existing with the British Virgin Islands [116]. - Potential adverse tax consequences may arise from transfer pricing adjustments by PRC tax authorities, impacting the company's financial condition [102]. - Changes in tax treatment for subsidiaries could increase overall tax liabilities, affecting profitability in future fiscal years [103]. Market Introduction and Approval Processes - The approval process for new seed varieties in China requires a minimum yield increase of 8% compared to control seeds, with successful candidates undergoing two growing seasons of testing in at least five locations [229]. - It typically takes a minimum of six years to bring a new seed variety to market, including three years for approval and three years for crop development [231]. - The introduction of the Corn Seed Green Pass Test System allows for faster market introduction of new hybrid varieties, with field tests conducted by the company itself [230].
Origin(SEED) - 2025 Q4 - Annual Report